Sita from the US is a Nutritionist, POTS and EDS patient who shares her health journey with us

Compounding Pharmacist Dr Erin Panian shares her LDN experience.

Treating depression in patients with autoimmune conditions a presentations for the LDN 2019 conference by Beth Livengood NMD

Pamela Smith, MD presented LDN Use in Cognitive Decline, Lyme Disease, and Hashimoto’s Thyroiditis at the LDN Research Trust 2019 Conference

Jill Brook, MA - Intermittent Fasting presentation at the LDN Research Trust 2019 Conference

Traumatic Brain Injury Presentation by Dr Sarah Zielsdorf at the LDN Research Trust Conference

Wiebke Pape MD Presents Dissociative Symptoms in Trauma-Related Disorders at the LDN Conference

Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)

Nutritionist Jill Brook from the US discusses LDN as a treatment for POTS and MCAS on the LDN Radio Show.

Dr. Weinstock discussed his plans for a documentary about MCAS, POTS, and ED, three conditions that are often misunderstood and difficult to manage. He hopes that by sharing the stories of patients and experts in the field, he can help educate the public and healthcare providers about these conditions.

Dr. Weinstock also emphasized the importance of working closely with healthcare providers to find the right treatment plan for each individual patient. While LDN may be a helpful tool for some, it's not a one-size-fits-all solution.

Overall, Dr. Weinstock's message is one of hope and determination. With continued research and awareness, there is potential for better outcomes and improved quality of life for those living with difficult-to-treat conditions.

If you would like to make a donation, please visit www.mcasfund.com. Your contribution, no matter how small, can make a difference. Thank you for your generosity!